What is Staphylococcus hominis bacteremia, how can I differentiate contamination from true infection, and what are the recommended management steps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Staphylococcus hominis Bacteremia: Understanding the Organism and Clinical Approach

Staphylococcus hominis is a coagulase-negative staphylococcus (CoNS) that normally lives on human skin and is most commonly a blood culture contaminant rather than a true pathogen, but when it causes genuine infection, it typically occurs in patients with intravascular catheters or devices and requires careful clinical correlation to distinguish from contamination 1.

What is Staphylococcus hominis?

S. hominis is a coagulase-negative staphylococcus that colonizes normal human skin as part of the natural flora. It belongs to the same family as the more notorious Staphylococcus aureus, but lacks the coagulase enzyme that makes S. aureus more virulent. While generally considered low-pathogenicity, S. hominis can cause serious infections including:

  • Catheter-related bloodstream infections (most common)
  • Native valve endocarditis (rare but documented) 2
  • Infections in immunocompromised patients 3

Critical caveat: S. hominis is increasingly showing multidrug resistance, with over 80% of clinical isolates demonstrating resistance to multiple antibiotics, including methicillin resistance in approximately 74% of strains 4. This makes empiric treatment decisions more complex.

Differentiating Contamination from True Infection

The single most important clinical challenge with S. hominis is determining whether a positive blood culture represents genuine bacteremia or contamination from skin flora during blood draw 1. This distinction directly impacts whether you expose patients to unnecessary antibiotics and their associated risks.

Use This Algorithmic Approach:

Step 1: Assess the number of positive blood culture sets

  • Multiple sets positive (≥2 sets): Strongly suggests true bacteremia 1, 5
  • Single set positive: More likely contamination, proceed to Step 2 5

Step 2: Evaluate time-to-positivity (TTP)

  • TTP ≤16 hours: Suggests high-grade bacteremia (>100 CFU/mL), likely true infection 6
  • TTP <24 hours with catheter present: Strongly suggests catheter-related bloodstream infection 5
  • TTP <48 hours with all 4 bottles positive: Likely true bacteremia 5
  • TTP >20 hours with single positive bottle: Likely contamination (<10 CFU/mL) 6

Step 3: Count SIRS criteria present The patient's systemic inflammatory response is highly predictive 7:

  • ≥3 SIRS criteria: 72.3% probability of true bacteremia
  • 2 SIRS criteria + central venous catheter: High probability of true bacteremia
  • ≤1 SIRS criterion: 42.4% probability, more likely contamination

SIRS criteria to assess:

  • Temperature >38°C or <36°C
  • Heart rate >90 bpm
  • Respiratory rate >20/min
  • WBC >12,000 or <4,000 cells/mm³

Step 4: Identify risk factors for true infection True S. hominis bacteremia is strongly associated with 7, 5:

  • Central venous catheter or intravascular device (OR 5.38) - most important predictor
  • Immunosuppression
  • Prosthetic valves or cardiac devices
  • Recent surgery or invasive procedures

Step 5: Look for clinical evidence of deep infection

  • New heart murmur or known valve disease (endocarditis risk) 2
  • Persistent fever despite catheter removal
  • Embolic phenomena (splenic/renal infarcts, discitis) 2
  • Hemodynamic instability or sepsis

Common Pitfalls to Avoid:

  1. Don't assume all single-positive CoNS cultures are contaminants - In patients with catheters and clinical signs of infection, even a single positive culture may represent true bacteremia 5

  2. Don't ignore polymicrobial cultures - Single-positive S. hominis cultures that are polymicrobial are statistically more likely to represent contamination 8

  3. Don't rely solely on culture results - The 2024 ASM guidelines emphasize that CoNS (including S. hominis) are simultaneously the most common contaminants AND the most common cause of catheter-related infections 9, 1

  4. Don't forget about S. lugdunensis - While not S. hominis, this related CoNS species behaves like S. aureus and requires aggressive treatment similar to S. aureus bacteremia 1

Management Recommendations

When You Determine It's TRUE Bacteremia:

For uncomplicated catheter-related S. hominis bacteremia 1:

If catheter is REMOVED:

  • Treat with antibiotics for 5-7 days
  • Choose antibiotics based on susceptibilities (expect methicillin resistance in ~74% of cases) 4
  • Vancomycin is typically first-line empirically until sensitivities return
  • All tested strains remain vancomycin-sensitive, though some show reduced susceptibility 4

If catheter is RETAINED (long-term catheter with no alternative access):

  • Treat with 10-14 days of systemic antibiotics
  • PLUS antibiotic lock therapy (high-concentration antibiotics instilled into catheter lumen)
  • Antibiotic lock can be left in place 24-48 hours
  • Once blood cultures clear and sepsis resolves, can transition to oral therapy (clindamycin, doxycycline, fluoroquinolone, or linezolid) combined with antibiotic lock 1

Alternative approach for uncomplicated cases 1:

  • If catheter removed AND patient has no intravascular/orthopedic hardware
  • Can observe without antibiotics if:
    • Repeat blood cultures (off antibiotics) are negative after catheter removal
    • Fever resolves within 72 hours
    • No signs of metastatic infection

For complicated infections (endocarditis, metastatic infection) 2:

  • Remove catheter immediately
  • Prolonged antibiotic therapy (4-6 weeks minimum)
  • Consider surgical intervention for endocarditis
  • Obtain echocardiography to evaluate for vegetations
  • Image for embolic complications (CT abdomen/pelvis, MRI spine if back pain)

When You Determine It's CONTAMINATION:

No antibiotic therapy required 6:

  • The low-colony-count group (<10 CFU/mL, TTP >20 hours) had favorable outcomes in 71% of cases without antibiotics
  • Central venous catheters were safely retained in 83% of contamination cases
  • Focus on proper blood culture technique to reduce future contamination rates (target <3%) 9

Special Populations:

Immunocompetent children without devices 10:

  • True S. hominis infection is exceedingly rare
  • Single positive culture with transient symptoms likely represents contamination
  • Clinical improvement with supportive care alone supports contamination diagnosis
  • Avoid unnecessary antibiotic exposure in this population

Immunocompromised patients 3:

  • Lower threshold for treating as true infection
  • S. hominis can cause severe manifestations (ecthyma gangrenosum reported)
  • Consider granulocyte transfusion in severe neutrophil dysfunction

Key Takeaway

The clinical context trumps the microbiology result. A positive S. hominis blood culture requires integration of: number of positive sets, time-to-positivity, presence of intravascular devices, SIRS criteria, and clinical trajectory. When in doubt with equivocal cases, repeat blood cultures off antibiotics provide the most definitive answer - if they remain negative after catheter removal, the original positive was likely contamination 1.

References

Research

Distinguishing coagulase-negative Staphylococcus bacteremia from contamination using blood-culture positive bottle detection pattern and time to positivity.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020

Research

How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.